Off-the-shelf CAR T-cells from iPSCs (with Prof Maria Themeli)
Prof. Maria Themeli tells about most recent developments in the field of “off-the-shelf” CAR T-cells. As the clinical success of advanced cellular therapies is growing, so is the need for broader access to these treatments. Listen as Prof. Themeli summarize the state-of-the-art technology that aims to generate “off-the-shelf” CAR T-cells from sources such as induced pluripotent stem cells (iPSCs) and how this approach may offer a feasible strategy to improve clinical outcomes and reduce the costs of advanced cellular therapies in the future.
Stay tuned for future episodes!
Host: Isabel…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.